Effects of Green Tea on Cardiometabolic Outcomes

University of Central Lancashire

Status: Not yet enrolling

Conditions: Cardiometabolic Syndrome

Treatments: Other: Placebo; Dietary Supplement: Green tea

Study type: Interventional

Funder types: Other

Identifiers

NCT06795438

Green tea cardiometabolic

Details and patient eligibility

About

Cardiovascular disease, type 2 diabetes mellitus and associated diseases combined are the leading health burden and cause of mortality worldwide; therefore, the necessity for an intervention is paramount. Dietary interventions to improve cardiometabolic health are highly sought after as they possess less risk than pharmacological drugs. It has been postulated that Green tea may be beneficial in improving cardiometabolic outcomes. However, to date, no research has explored this using a placebo randomized intervention.

Enrollment: 40 estimated patients

Sex: All

Ages: 18 to 65 years old

Volunteers: Accepts Healthy Volunteers

Inclusion criteria

• Healthy
• Between 18 & 65 years
• Non-smoker
• BMI < 30
• Able to give informed consent

Exclusion criteria

• Pregnancy
• Diabetes or any other metabolic/ uncontrolled hypertensive conditions
• Food allergies to quercetin
• Habitual consumption of quercetin
• Not regularly taking medication or antioxidant supplements

Trial design

Primary purpose: Prevention

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Double Blind

---

40 participants in 2 patient groups, including a placebo group

Green tea

Experimental group

Description:

Green tea tablets 1000mg 1 x per day

Treatment:

Dietary Supplement: Green tea

Placebo

Placebo Comparator group

Description:

Placebo control 1 x blinded placebo tablet per day

Treatment:

Other: Placebo